Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium
Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium
复制标题
DOI:
10.1016/j.contraception.2012.09.023
复制
发表时间:
2013-06-01
期刊:
影响因子:
2.9
通讯作者:
Ferriani, Rui Alberto
中科院分区:
文献类型:
--
作者:
Franceschini, Silvio Antonio;Vieira, Carolina Sales;Ferriani, Rui Alberto
Background: Although the use of combined oral contraceptives (COCs) is associated with an increased risk of arterial and venous thromboembolic events, less is known about the impact of COCs on endothelial function. The present study evaluated the effects on the endothelium of healthy women of combinations of 30 mcg ethinylestradiol (EE)/2 mg chlormadinone acetate (CMA) and 30 mcg EE/150 mcg levonorgestrel (LNG).Study Design: Sixty-four healthy women were evaluated, 21 using a nonhormonal contraceptive method (control) and 43 using COCs, randomized to EE 30 mcg /CMA 2 mg or to EE 30 mcg/LNG 150 mcg. Anthropometric parameters, systolic arterial pressure (SAP), diastolic arterial pressure (DAP), ultrasound markers of endothelial function, flow-mediated dilation (FMD) of the brachial artery, intima media thickness (IMT) and common carotid artery stiffness were measured at randomization and 6 months later.Results: Relative to baseline, EE/CMA users showed a significant reduction in mean DAP at 6 months (p=.02), and EE/LNG users showed a significant increase in mean IMT (p=.02) and a significant reduction in mean FMD (p=.01) at 6 months. DAP at 6 months was significantly lower in COC users than in controls (p=.01). Intergroup evaluations showed that, at 6 months, mean SAP (p=.02) was significantly lower in EE/LNG users than in controls (p=.02) and that mean DAP was significantly lower in EE/CMA (p